Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14176589 | 1.00 | USP2 (0.33) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL18262 | 0.97 | — | — | |
| SCHEMBL18353 | 0.92 | — | — | |
| SCHEMBL178384 | 0.85 | — | — | |
| Methyl Alcohol SCHEMBL28179853 | 0.82 | ALDH1A1 (0.36) | USP2ALDH1A1LMNACYP1A2TSHR | |
| Methyl Alcohol SCHEMBL27831139 | 0.82 | ALDH1A1 (0.36) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL15187 | 0.82 | ALDH1A1 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL5673171 | 0.82 | ALDH1A1 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL153517 | 0.82 | ALDH1A1 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL22444527 | 0.82 | ALDH1A1 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112480937-B | Liquid crystal compound, liquid crystal composition, liquid crystal display element, and liquid crystal display | 石家庄诚志永华显示材料有限公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20230019032-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| EP-3576743-B1 | 5-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-5-AZASPIRO[2 5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS JAK KINASE INHIBITORS | LEO PHARMA AS (DK) | 2023-01-18 | — | — | EP | disclosed |
| CN-112859516-A | Material for forming organic film, method for forming pattern, and polymer | 信越化学工业株式会社 | 2021-05-28 | — | — | CN | disclosed |
| CN-112480937-A | Liquid crystal compound, liquid crystal composition, liquid crystal display element, and liquid crystal display | 石家庄诚志永华显示材料有限公司 | 2021-03-12 | — | — | CN | disclosed |
| US-10703882-B2 | Plastic composition, production method, and use of same | ATP AICHER + TROBS PRODUKTENTWICKLUNG GMBH (DE) | 2020-07-07 | — | — | US | disclosed |
| EP-3510092-B1 | PLASTIC COMPOSITION, PRODUCTION METHOD, AND USE OF SAME | ATP AICHER TROEBS PRODUKTENTWICKLUNG GMBH (DE) | 2020-03-04 | — | — | EP | disclosed |
| US-10457669-B2 | Benzolactam compounds as protein kinase inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-10-29 | — | — | US | disclosed |
| EP-3134396-B1 | AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | NOVARTIS AG (CH) | 2019-09-18 | — | — | EP | disclosed |
| EP-3510092-A1 | PLASTIC COMPOSITION, PRODUCTION METHOD, AND USE OF SAME | ATP Aicher + Tröbs Produktentwicklung GmbH (DE) | 2019-07-17 | — | — | EP | disclosed |
| US-20190047990-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
| CN-109207159-A | A kind of liquid-crystal compounds of negative dielectric anisotropic and the preparation method and application thereof | 北京八亿时空液晶科技股份有限公司 | 2019-01-15 | — | — | CN | disclosed |
| WO-2018141587-A1 | PLASTIC COMPOSITION, PRODUCTION METHOD, AND USE OF SAME | ATP Aicher + Tröbs Produktentwicklung GmbH (DE) | 2018-08-09 | — | — | WO | disclosed |
| CN-105263490-B | Substituted triazolopyridines and methods of use | 基因泰克公司 | 2018-05-22 | — | — | CN | disclosed |
| US-20170081317-A1 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| US-20170042889-A1 | AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | NOVARTIS AG (CH) | 2017-02-16 | — | — | US | disclosed |
| US-20170037032-A1 | AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | NOVARTIS AG (CH) | 2017-02-09 | — | — | US | disclosed |
| WO-2012025857-A1 | CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS | HETERO RESEARCH FOUNDATION (IN) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012025857-A1 | CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS | HETERO RESEARCH FOUNDATION (IN) | 2012-03-01 | — | — | WO | disclosed |
| US-4231915-A | HEAT RESISTANCE, DIELECTRICS, GOOD GELLING AND TENSILE STRENGTH | CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) | 1980-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037032-A1 | AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | PI4KA, PIP4K2B, PHKG1 | USP2 3841/4885ALDH1A1 3680/4885LMNA 3360/4885 |
| US-20170081317-A1 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | USP2 1588/4885ALDH1A1 2580/4885LMNA 1351/4885 |
| US-20230019032-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | MAPK1, ALK, MAP3K1 | USP2 3288/4885ALDH1A1 1598/4885LMNA 816/4885 |
| US-20190047990-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | MAPK1, ALK, MAP3K1 | USP2 3288/4885ALDH1A1 1598/4885LMNA 816/4885 |
| US-10457669-B2 | Benzolactam compounds as protein kinase inhibitors | MAPK1, ALK, MAP3K1 | USP2 3288/4885ALDH1A1 1598/4885LMNA 816/4885 |
| US-20170042889-A1 | AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | PI4KA, PIP5K1B, PIP4K2B | USP2 3731/4885ALDH1A1 3615/4885LMNA 3843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.